Navigation Links
Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study
Date:1/30/2009

INDIANAPOLIS, Jan. 30 /PRNewswire-FirstCall/ -- In a new study, Cymbalta (duloxetine HCl) 60-120 mg, taken once daily, reduced pain severity significantly, compared with placebo, in patients with osteoarthritis pain of the knee. Data from the 13-week randomized, double-blind, placebo-controlled clinical trial(1) were presented at the annual meeting of the American Academy of Pain Medicine (AAPM) in Honolulu, Hawaii.

Duloxetine-treated patients showed greater reductions from baseline on the primary endpoint, the 24-hour average pain score on the Brief Pain Inventory (BPI), compared with placebo-treated patients. In the study, 65 percent of duloxetine-treated patients experienced a clinically significant (at least 30 percent) improvement in pain, compared with 44 percent of placebo-treated patients.

The duloxetine-treated patients also showed improved physical function, compared with placebo-treated patients, as measured by the Western Ontario and McMaster Osteoarthritis Index (WOMAC). In this study, patients on duloxetine did not show statistically significant improvements on the WOMAC pain and stiffness subscales compared with placebo.

"The disabling nature of osteoarthritis pain can greatly impact a person's life," said Vladimir Skljarevski, M.D., a study author and medical fellow at Eli Lilly and Company. "As our population ages, osteoarthritis of the knee is likely to become an increasing problem."

The most common adverse events in the study (occurred at a rate of greater than or equal to 5 percent and at least twice the rate of placebo) included nausea, constipation and excessive sweating (hyperhidrosis). Adverse events were similar to those seen in previous duloxetine studies.

Additional Study Highlights

-- Compared with patients receiving placebo, patients receiving duloxetine experienced additional improvements associated with osteoarthritis
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
2. Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
3. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
4. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
5. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
6. AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly
7. Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy
8. Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome
9. GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
10. Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death
11. Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... -- The legalization of medical and recreational marijuana is ... new economic driver – that has taken legislators by ... response to the will of the people about a ... a National Press Club Newsmakers news conference on Thursday, ... the area of marijuana legalization will discuss its far-reaching ...
(Date:7/14/2014)... 2014 Decision Resources Group finds that ... perceptions of emerging drugs for both oncologists and ... (50 medical oncologists and 50 hematological oncologists) and ... care organizations (MCOs), reveals that despite lower familiarity ... of payers say this designation will likely influence ...
(Date:7/14/2014)... HAMILTON, N.J. , July 14, 2014 /PRNewswire/ ... Group, LLC is pleased to announce that its ... the Association for the Assessment and Accreditation of ... humane treatment of animals in science worldwide through ... highest standards for animal care and use in ...
Breaking Medicine Technology:NPC Newsmaker Program: Interpreting smoke signals from the marijuana skirmish line 2Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 2Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 3Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use 2
... Accuray Incorporated, (Nasdaq:  ARAY), a global leader in the ... leading academic institutions using CyberKnife radiosurgery in breast cancer ... Southwestern and Fox Chase Cancer Center, will be presented ... for Radiation Oncology (ASTRO) in San Diego from October ...
... 30 Researchers from the University of Bari, Italy, ... creates a sustained viral response (SVR) and protects them ... to determine the long-term clinical outcomes of patients posttransplant ... (HCV) infection of the liver graft. ...
Cached Medicine Technology:CyberKnife Radiosurgery for Early-Stage Breast Cancer 2CyberKnife Radiosurgery for Early-Stage Breast Cancer 3CyberKnife Radiosurgery for Early-Stage Breast Cancer 4CyberKnife Radiosurgery for Early-Stage Breast Cancer 5CyberKnife Radiosurgery for Early-Stage Breast Cancer 6Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes 2
(Date:7/14/2014)... Wisconsin (PRWEB) July 14, 2014 Secure ... software security, is partnering with the Software Assurance Marketplace ... to improve the software that drives everyday life. , ... institutions and housed in the Morgridge Institute for Research, ... S&T to advance software security practices by building a ...
(Date:7/14/2014)... 13, 2014 (HealthDay News) -- Along with improving vision, ... Alzheimer,s disease and other types of dementia, a new ... of life, the researchers said. "These preliminary results ... benefits for people with dementia and their loved ones, ... Case Western Reserve University and University Hospitals Case Medical ...
(Date:7/14/2014)... 2014 (HealthDay News) -- Being physically active in middle ... disease and other types of dementia, suggest the findings ... found that physical exercise at various levels, especially in ... from the Mayo Clinic, said in an Alzheimer,s Association ... are not yet conclusive. More research is needed to ...
(Date:7/14/2014)... By Amy Norton ... -- Older adults who enjoy mentally stimulating games may have ... research suggests. The study looked at the connection between ... mental acuity for adults in their 50s and 60s. ... every other day performed better on tests of memory and ...
(Date:7/14/2014)... KeyPoint Credit Union is teaming up ... run and one-mile family fun walk. The run begins ... and finishes inside Levi’s® Stadium. , Over the past ... the Mission City Community Fund. All proceeds benefit education, ... Seasoned athletes, part-time pavement-pounders and walkers are invited to ...
Breaking Medicine News(10 mins):Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 3Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2Health News:Staying Active May Help Prevent Dementia 2Health News:Can Games, Puzzles Keep Aging Minds Sharp? 2Health News:Can Games, Puzzles Keep Aging Minds Sharp? 3
... for patient ... care, ... Sutter Health hospitals currently in,bargaining have voted overwhelmingly to authorize a strike ... Nurses Organizing Committee announced today. There has,been no progress in bargaining over ...
... for humans, it offered immunity for at least 6 months ... anthrax vaccine proved highly effective in tests in mice and ... , After it was placed inside the animals, noses, the ... survived after they received injections of 1,000 times the lethal ...
... AMCS ),a leader in radiology and medical image and information ... the,Thomas Weisel Partners Healthcare Conference 2007 being held in Boston. ... -- Thursday, September 6, 2007 ... a.m. (Eastern Time), ...
... Cleveland-based The ScottCare,Corporation, a leader in ... telemetry, announced today that,the company has completed ... Rozinn Electronics, Inc., a privately-held market leader ... "We are very pleased to welcome ...
... BlueShield of South,Carolina has created a new division ... Davis to vice president in charge of the ... CEO M. Edward Sellers and is,responsible for enhancing ... a corporate-wide executive development program. "We are ...
... the September issue of The American Naturalist, Juan Carranza ... Javier Prez-Barber a (Macaulay Institute, United Kingdom) offer a ... to intense competition are born with lower survival expectancies ... smaller molars relative to their body size and ...
Cached Medicine News:Health News:Nurses Send Sutter a Clear Message 2Health News:Nurses Send Sutter a Clear Message 3Health News:AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007 2Health News:The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products 2Health News:S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President 2
... InterStim Therapy for Urinary Control offers ... retention and the symptoms of overactive ... significant symptoms of urgency-frequency alone or ... failed or could not tolerate more ...
... 4 Conti is a battery operated dual-channel therapy ... conditions described below. ELPHA 4 Conti also includes ... and faecal incontinence ELPHA 4 Conti provokes a ... user can feel which muscles need exercising. In ...
... Template Set is the HDR solution which ... technique. The template set consists of a ... sutured to the patient and is placed ... Grid Face Plates. The Stepper Holder is ...
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
Medicine Products: